Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments

Antibody‐mediated rejection (AMR) remains one of the most critical problems in renal transplantation, with a significant impact on patient and graft survival. In the United States, no treatment has received FDA approval jet. Studies about treatments of AMR remain controversial, limited by the absenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertacchi, Massimiliano, Parvex, Paloma, Villard, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286805/
https://www.ncbi.nlm.nih.gov/pubmed/35137982
http://dx.doi.org/10.1111/ctr.14608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286805/
https://www.ncbi.nlm.nih.gov/pubmed/35137982
http://dx.doi.org/10.1111/ctr.14608

Ejemplares similares